Global Pediatric Drugs market size is expected to reach $308.57 billion by 2029 at 14.5%, impact of growing preterm births on the market growth
Read MoreGlobal Orencia Abatacept Drug market size is expected to reach $4.98 billion by 2029 at 6.1%, rising incidence of autoimmune disorders fuels demand for biologic therapies
Read MoreGlobal Octreotide market size is expected to reach $3.11 billion by 2029 at 5.0%, rising cancer rates fuel growth in the market
Read MoreGlobal Metronidazole market size is expected to reach $0.76 billion by 2029 at 5.5%, increasing incidence of bacterial infections propels the market growth
Read MoreGlobal Entecavir market size is expected to reach $0.87 billion by 2029 at 4.1%, rising incidence of liver diseases driving the growth of the market
Read MoreGlobal Donepezil market size is expected to reach $1.24 billion by 2029 at 4.5%, rising alzheimer’s cases propel growth of the market
Read MoreGlobal Lipid Regulators market size is expected to reach $9.86 billion by 2029 at 6.2%, segmented as by lipid regulators, statins, fibrates, niacin, omega-3 fatty acids
Read MoreGlobal Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Inhibitors market size is expected to reach $20.29 billion by 2029 at 14.3%, impact of growing oncology research investment on advancements in cancer treatment
Read MoreGlobal Leukotriene Modifiers market size is expected to reach $29.25 billion by 2029 at 5.6%, segmented as by montelukast, tablet formulation, chewable tablet formulation, oral granules
Read MoreGlobal Lenalidomide market size is expected to reach $16.88 billion by 2029 at 7.2%, segmented as by type, 5mg capsules, 10mg capsules, 15mg capsules, 25mg capsules
Read More